93
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance

, , , , , , , , & show all
Pages 2081-2108 | Published online: 16 Mar 2017

References

  • GottesmanMMFojoTBatesSEMultidrug resistance in cancer: role of ATP-dependent transportersNat Rev Cancer200221485811902585
  • HuCMAryalSZhangLNanoparticle-assisted combination therapies for effective cancer treatmentTher Deliv20101232333422816135
  • PintoACMoreiraJNSimõesSCombination chemotherapy in cancer: principles, evaluation and drug delivery strategiesÖzdemirÖCurrent Cancer Treatment–Novel Beyond Conventional ApproachesCroatiaInTech2011693714
  • KangLGaoZHuangWJinMWangQNanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatmentActa Pharm Sin B20155316917526579443
  • TeoPYChengWHedrickJLYangYYCo-delivery of drugs and plasmid DNA for cancer therapyAdv Drug Deliv Rev201698416326529199
  • RamasamyTRuttalaHBChoiJYEngineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecanChem Commun (Camb)201551265758576125720556
  • RamasamyTKimJHChoiJYpH sensitive polyelectrolyte complex micelles for highly effective combination chemotherapyJ Mater Chem B201423763246333
  • RamasamyTKimJChoiHGYongCSKimJONovel dual drug-loaded block ionomer complex micelles for enhancing the efficacy of chemotherapy treatmentsJ Biomed Nanotechnol20141071304131224804551
  • RamasamyTHaidarZSTranTHLayer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugsActa Biomater201410125116512725169256
  • YiXLianXDongJCo-delivery of pirarubicin and paclitaxel by human serum albumin nanoparticles to enhance antitumor effect and reduce systemic toxicity in breast cancersMol Pharm201512114085409826422373
  • LvSTangZLiMCo-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancerBiomaterials201435236118612924794923
  • GuoSLinCMXuZMiaoLWangYHuangLCo-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulationACS Nano2014854996500924720540
  • JiangTMoRBellottiAZhouJGuZGel–liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacyAdv Funct Mater2014241622952304
  • DaiXTanCCombination of microRNA therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriersAdv Drug Deliv Rev20158118419725281917
  • WangYGaoSYeWHYoonHSYangYYCo-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymerNat Mater200651079179616998471
  • HeCTangZTianHChenXCo-delivery of chemotherapeutics and proteins for synergistic therapyAdv Drug Deliv Rev201698647626546464
  • KempJAShimMSHeoCYKwonYJ“Combo” nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapyAdv Drug Deliv Rev20169831826546465
  • KothariAHittelmanWNChambersTCCell cycle-dependent mechanisms underlie vincristine-induced death of primary acute lymphoblastic leukemia cellsCancer Res201676123553356127197148
  • RathiAHittelmanWChambersTDistinct pathways of vincristine induced cell death in primary acute lymphoblastic leukemia cellsFASEB J2015291 Suppl884883
  • TacarOSriamornsakPDassCRDoxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systemsJ Pharm Pharmacol201365215717023278683
  • DeclèvesXReginaALaplancheJLFunctional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytesJ Neurosci Res200060559460110820430
  • OhnishiTTamaiISakanakaKIn vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrierBiochem Pharmacol19954910154115447763297
  • ZhangYYangCWangWCo-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancerSci Rep201662122526876480
  • WangDFRongWTLuYTPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cellsACS Appl Mater Interfaces2015773888390125644220
  • ChenCXieXXZhouQEGF-functionalized single-walled carbon nanotubes for targeting delivery of etoposideNanotechnology201223404510422222202
  • GuoMRongWTHouJMechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecinNanotechnology2013242424510123702815
  • WangYGuoMLuYAlpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitroNanotechnology2012234949510323149859
  • WangYYZhangDDKongYYCS/PAA@TPGS/PLGA nano-particles with intracellular pH-sensitive sequential release for delivering drug to the nucleus of MDR cellsColloids Surf B Biointerfaces201614571672727289313
  • WebbBAChimentiMJacobsonMPBarberDLDysregulated pH: a perfect storm for cancer progressionNat Rev Cancer201111967167721833026
  • JuCMoRXueJSequential intra-intercellular nanoparticle delivery system for deep tumor penetrationAngew Chem Int Ed Engl201453246253625824740532
  • LiPDaiYNZhangJPWangAQWeiQChitosan-alginate nano-particles as a novel drug delivery system for nifedipineInt J Biomed Sci20084322122823675094
  • MukhopadhyayPChakrabortySBhattacharyaSMishraRKunduPPpH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin deliveryInt J Biol Macromol20157264064825239194
  • WangHXieXZhangFEvaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel β-cyclodextrin derivativesFood Chem Toxicol20114961387139321426923
  • ChouTCDrug combination studies and their synergy quantification using the Chou-Talalay methodCancer Res201070244044620068163
  • OrensteinAKostenichGRoitmanLA comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma modelBr J Cancer19967389379448611429
  • DongXWangWQuHHanDZhengJSunGTargeted delivery of doxorubicin and vincristine to lymph cancer: evaluation of novel nanostructured lipid carriers in vitro and in vivoDrug Deliv20162341374137826208133
  • MoRSunQLiNZhangCIntracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipidsBiomaterials201334112773278623352118
  • ZhangWShenJSuHCo-delivery of cisplatin prodrug and chlorin e6 by mesoporous silica nanoparticles for chemo-photodynamic combination therapy to combat drug resistanceACS Appl Mater Interfaces2016821133321334027164222
  • FanWShenBBuWDesign of an intelligent sub-50 nm nuclear-targeting nanotheranostic system for imaging guided intranuclear radiosensitizationChem Sci20156317471753
  • MartensTFRemautKDemeesterJDe SmedtSCBraeckmansKIntracellular delivery of nanomaterials: how to catch endosomal escape in the actNano Today201493344364
  • HsiaoMHLinKHLiuDMImproved pH-responsive amphiphilic carboxymethyl-hexanoyl chitosan-poly(acrylic acid) macromolecules for biomedical applicationsSoft Matter20139824582466
  • WuWZhangQWangJTumor-targeted aggregation of pH-sensitive nanocarriers for enhanced retention and rapid intracellular drug releasePolym Chem201451956685679
  • AziziENamaziAHaririanIRelease profile and stability evaluation of optimized chitosan/alginate nanoparticles as EGFR antisense vectorInt J Nanomedicine2010545546120957167
  • LiTShiXWDuYMTangYFQuaternized chitosan/alginate nanoparticles for protein deliveryJ Biomed Mater Res A200783238339017450586
  • LiZQiuLChenQpH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug deliveryActa Biomater20151113715025242647
  • QiuLQiaoMChenQEnhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicinBiomaterials201435379877988725201738
  • ZhuHChenHZengXCo-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistanceBiomaterials20143572391240024360574
  • BinetSChaineauEFellousAImmunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubulesInt J Cancer19904622622662200754
  • MichaelisMRothweilerFKlassertDReversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3Cancer Res200969241642119147553
  • ZhangZTanSFengSSVitamin E TPGS as a molecular biomaterial for drug deliveryBiomaterials201233194889490622498300
  • CollnotEMBaldesCWempeMFMechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidityMol Pharm20074346547417367162
  • IsmaelGFRosaDDManoMSAwadaANovel cytotoxic drugs: old challenges, new solutionsCancer Treat Rev2008341819117905518